Charles River scientists have pioneered ion channel research for nearly 20 years, creating more than 120 functionally validated assays and cell lines. This industry-leading expertise, combined with our wide array of technologies for screening, profiling and mechanism of action (MOA) studies, makes us unmatched in our ability to support our partners’ quests for the discovery of novel ion channel therapeutics.